Trying to get mental health or substance use disorder treatment covered by insurance can feel confusing fast. A claim gets denied. Prior authorization drags on. A therapist, psychiatrist, or treatment program is suddenly “out of network” in practice, even when the plan looks workable on paper. For many people, the hardest part is figuring out whether this is just routine insurance friction or whether the plan may be treating behavioral health care more harshly than medical or surgical care.
That question sits at the center of mental health parity.
In simple terms, federal parity rules generally aim to prevent health plans from putting more restrictive financial requirements or treatment limits on mental health and substance use disorder benefits than they place on comparable medical and surgical benefits. The main federal law is the Mental Health Parity and Addiction Equity Act, often called MHPAEA. The Affordable Care Act also expanded protections by requiring mental health and substance use disorder services as an essential health benefit category in non-grandfathered individual and small-group plans. CMS explains the law and its scope here, and HealthCare.gov summarizes consumer protections here.
In this post you’ll learn what mental health parity is, what unequal coverage can look like, what documents often matter, how appeals and external review may fit in, and when an attorney may help sort out whether a denial is part of a larger parity problem. If you want a deeper dive into the rules behind these disputes, this overview of how unequal behavioral health coverage often shows up in plan design and administration can add useful context.
<aside> 💡 Scroll to the bottom for every post in this series.
</aside>
At a high level, parity is about equal treatment between behavioral health benefits and medical/surgical benefits.
According to CMS, MHPAEA generally prevents plans that offer mental health or substance use disorder benefits from imposing less favorable benefit limitations on those benefits than on medical/surgical benefits. That includes familiar limits like copays, coinsurance, and visit caps, but it also reaches less obvious restrictions such as prior authorization, medical necessity review, provider network standards, reimbursement methods, and fail-first requirements. CMS’s MHPAEA page and the Department of Labor’s participant fact sheet on the 2024 parity rules both describe those protections.
That last category is where many disputes live. These are often called nonquantitative treatment limitations, or NQTLs. If that term sounds technical, think of it this way: an NQTL is a rule that affects access to care without setting a number like “20 visits per year.” Prior authorization rules, step therapy, standards for joining a provider network, and how a plan decides what is “medically necessary” can all function as NQTLs. If you want a more detailed explanation of those concepts, this piece on how NQTLs and comparative analyses can drive unequal coverage is the natural next read.
Parity disputes are not just technical compliance issues. They can affect whether someone can realistically access therapy, medication management, inpatient care, residential treatment, intensive outpatient treatment, or substance use disorder services.
Federal agencies have repeatedly said that plans and issuers are still falling short. In January 2025, the U.S. Departments of Labor, Health and Human Services, and Treasury reported that plans and insurers were making progress, but were continuing to fall short of covering mental health and substance use disorder benefits in parity with medical/surgical benefits. The Department of Labor also said enforcement corrections had directly benefited more than 7.6 million participants in more than 72,000 plans. Those figures come from the 2024 MHPAEA Report to Congress release.
At the same time, denials and appeals remain a broader consumer problem across health coverage. A March 2026 KFF analysis found that ACA Marketplace insurers denied about 19% of in-network claims in 2024, and earlier KFF work found that only a tiny fraction of denied claims are appealed. KFF’s 2024 claims denial analysis and its earlier review of denials and appeals help show why many questionable denials never get fully tested.
For people dealing with behavioral health treatment, that gap can matter a lot. A denial may look isolated when it first arrives. In some cases, though, it may reflect a plan-wide rule or internal process that treats behavioral health care differently than comparable medical care.
A parity problem does not always come labeled as one. It often shows up as a practical barrier.
Here are a few common examples:
A plan may require repeated prior authorizations for therapy, intensive outpatient treatment, residential treatment, or medication-assisted treatment, while similar medical services move with fewer hurdles. Federal regulators have specifically identified prior authorization and other medical management techniques as NQTLs that can create parity concerns. CMS discusses that here.